Giuseppe
Emeritus
[Source: World Health Organization, full PDF document: (LINK). Extract.]
Middle East Respiratory Syndrome Coronavirus (MERS-CoV), Initial Interview Questionnaire of Cases - Guide for the interviewer
Purpose of form:
This interview form is developed as a supplemental tool to accompany the WHO guidelines for investigation of cases of human infection with MERS-CoV, which can be found on the WHO website.1 It is designed to gather initial information about the potential exposures of a suspected or confirmed case of MERS-CoV infection in the 14 days before symptom onset.
The interview should be conducted as soon as possible once the patient is suspected of having MERS-CoV infection.
If the patient is unable to personally answer questions because of death or severity of illness, a close relative or friend can answer the questions for him or her.
This form should be modified according to local needs and experience. It is not intended as a formal study instrument but rather contains many open-ended questions that will allow investigators to develop hypotheses to test during subsequent formal studies. However, the questions about specific exposures are also contained in the WHO Case-control study to assess potential risk factors related to human illness caused by MERS-CoV,1 which may be used for follow-up investigation. The information gathered in this interview could be used in that study as well.
(?)
_________
1 WHO Case control study protocol for non-human exposures that result in MERS-CoV infection: http://www.who.int/csr/disease/coronavirus_infections/en/index.html
2 An identification number assigned by investigators. The number enables personal identifiers to be removed from the data set but still allows data to be linked to laboratory results and other cases.
-
-------
Middle East Respiratory Syndrome Coronavirus (MERS-CoV), Initial Interview Questionnaire of Cases - Guide for the interviewer
Purpose of form:
This interview form is developed as a supplemental tool to accompany the WHO guidelines for investigation of cases of human infection with MERS-CoV, which can be found on the WHO website.1 It is designed to gather initial information about the potential exposures of a suspected or confirmed case of MERS-CoV infection in the 14 days before symptom onset.
The interview should be conducted as soon as possible once the patient is suspected of having MERS-CoV infection.
If the patient is unable to personally answer questions because of death or severity of illness, a close relative or friend can answer the questions for him or her.
This form should be modified according to local needs and experience. It is not intended as a formal study instrument but rather contains many open-ended questions that will allow investigators to develop hypotheses to test during subsequent formal studies. However, the questions about specific exposures are also contained in the WHO Case-control study to assess potential risk factors related to human illness caused by MERS-CoV,1 which may be used for follow-up investigation. The information gathered in this interview could be used in that study as well.
(?)
_________
1 WHO Case control study protocol for non-human exposures that result in MERS-CoV infection: http://www.who.int/csr/disease/coronavirus_infections/en/index.html
2 An identification number assigned by investigators. The number enables personal identifiers to be removed from the data set but still allows data to be linked to laboratory results and other cases.
-
-------